Good News for an Aging Population: Incidence of Stroke in the Elderly Has Dropped by 40% Over the Last 20 Years
Rates Declined for Ischemic and Hemorrhagic Stroke and Mortality in Both Men and Women 65 Years and Older, Reports The American Journal of Medicine
Philadelphia, PA, July 17, 2014
A new analysis of data from 1988-2008 has revealed a 40% decrease in the incidence of stroke in Medicare patients 65 years of age and older. This decline is greater than anticipated considering this population’s risk factors for stroke, and applies to both ischemic and hemorrhagic strokes. Investigators also found death resulting from stroke declined during the same period. Their findings are published in the July issue of The American Journal of Medicine.
Preventable but deadly, stroke is the fourth leading cause of mortality in the United States, with approximately 795,000 strokes occurring each year. Beyond the impact on patients, treatment and after care place high demands on doctors and health care facilities. With an aging population reaching Medicare age, deconstructing and studying stroke statistics are important for understanding the causes underlying this downward trend, benefiting both patients and providers.
“Shedding light on trends in the burden of stroke among Medicare beneficiaries may provide important informationfor policy purposes, including describing the past and current scope of the condition, assessing the potential effect of stroke prevention interventions on a national level, and identifying areas where resources can be targeted more specifically and effectively,”says lead investigator Margaret C. Fang, MD, MPH, an Associate Professor of Medicine at the University of California San Francisco School of Medicine, who also serves as the Medical Director of the UCSF Anticoagulation Clinic.
The study was constructed to analyze stroke cases over the past two decades, not to investigate causation; however, researchers did find evolving patterns in the risk factors associated with strokes. Although the prevalence of diabetes mellitus increased over time, other risk factors, such as cigarette smoking, measured systolic blood pressure, and total cholesterol values, decreased.
The decline in stroke rates paralleled increasing use of antihypertensive and statin medications and might explain the reduction in stroke rates. “Antihypertensive medications reduce the risk of stroke by approximately 32% and statins by approximately 21%. Stroke rates seem to decrease most sharply after year 1998, approximately when statin use became more prevalent,” explains Dr. Fang. “If true, then this illustrates how medical interventions have resulted in significant improvements in health on a population level.”
Investigators analyzed occurrence data from a sample of Medicare patients diagnosed as having suffered a stroke. Risk factors such as high blood pressure, diabetes, smoking status, and high lipid levels were gathered from the National Health and Nutrition Examination Survey (NHANES). The Medicare Current Beneficiary Survey was used to determine medication use.
The team identified more than one million stroke events from 1988 to 2008, of which 87.3% were ischemic and 12.7% hemorrhagic strokes. The analysis showed a reduction in ischemic strokes from 927 per 100,000 in 1988 to just 545 per 100,000 in 2008. Hemorrhagic strokes decreased from 112 per 100,000 to 94 per 100,000 over the same time period, primarily among men.
Data indicated that stroke mortality also declined. The risk-adjusted 30-day mortality rate for ischemic strokes fell from 15.9% in 1988 to 12.7% in 2008. For hemorrhagic stroke, the mortality rates declined slightly from 44.7% in 1988 to 39.3% in 2008.
Dr. Fang notes that “Our analysis confirms the continuing and devastating effect of hemorrhagic stroke, but was unable to assess for casual factors influencing mortality rates; relatively few interventions have been shown to reduce stroke-related mortality. Timely administration of intravenous thrombolytics is associated with more favorable outcomes from ischemic stroke, but has not been shown to have significant effects on mortality. In addition, the rate of thrombolytic administration continues to be low in the United States.”
Notes for editors
"Trends in Stroke Rates, Risk, and Outcomes in the United States, 1988 to 2008,” by Margaret C. Fang, MD, MPH, Marcelo Coca Perraillon, MA, Kaushik Ghosh, PhD, David M. Cutler, PhD, Allison B. Rosen, MD, MPH, ScD (DOI: http://dx.doi.org/10.1016/j.amjmed.2014.03.017) appears in The American Journal of Medicine, Volume 127/Issue 7 (July 2014) published by Elsevier.
Full text of the article is available to credentialed journalists upon request. Contact Jane Grochowski at +1 215 239 3712 or firstname.lastname@example.org to obtain copies. Journalists wishing to interview Margaret C. Fang, MD, MPH, may contact her directly at email@example.com.
About The American Journal of Medicine
The American Journal of Medicine (http://www.amjmed.com), known as the “Green Journal,” is one of the oldest and most prestigious general internal medicine journals published in the United States. It has an Impact Factor of 4.768, which ranks it 13 out of 151 General and Internal Medicine titles according to the 2012 Journal Citation Reports® published by Thomson Reuters.
AJM, the official journal of The Association of Professors of Medicine, a group comprised of chairs of departments of internal medicine at 125-plus US medical schools, publishes peer-reviewed, original scientific studies that have direct clinical significance. The information contained in this article in The American Journal of Medicine is not a substitute for medical advice or treatment, and the Journal recommends consultation with your physician or healthcare professional. AJM is published by Elsevier.
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we’re committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX Group, a global provider of information and analytics for professionals and business customers across industries. www.elsevier.com
+1 215 239 3712